Small airways targeted treatment with smart nebulizer technology could improve severe asthma in children: a retrospective analysis

References

• Larsson K, Ställberg B, Lisspers K, Telg G, Johansson G, Thuresson M, Janson C. Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR). Respir Res. 2018;19(1):12. doi:10.1186/s12931-018-0719-x.
   PubMed Web of Science ®Google Scholar
• Ahmed H, Turner S. Severe asthma in children-a review of definitions, epidemiology, and treatment options in 2019. Pediatr Pulmonol. 2019;54(6):778–787. doi:10.1002/ppul.24317.
   PubMed Web of Science ®Google Scholar
• Jansson S-A, Backman H, Andersson M, Telg G, Lindberg A, Stridsman C, Lundbäck B, Rönmark E. Severe asthma is related to high societal costs and decreased health related quality of life. Respir Med. 2020;162:105860. doi:10.1016/j.rmed.2019.105860.
   PubMed Web of Science ®Google Scholar
• Hossny E, Caraballo L, Casale T, El-Gamal Y, Rosenwasser L. Severe asthma and quality of life. World Allergy Organ J. 2017;10(1):28. doi:10.1186/s40413-017-0159-y.
   PubMed Web of Science ®Google Scholar
• Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3(1).
   PubMedGoogle Scholar
• Pijnenburg MW, Fleming L. Advances in understanding and reducing the burden of severe asthma in children. Lancet Respir Med. 2020;8(10):1032–1044. doi:10.1016/S2213-2600(20)30399-4.
   PubMed Web of Science ®Google Scholar
• Johnson N, Varughese B, De La Torre MA, Surani SR, Udeani G. A review of respiratory biologic agents in severe asthma. Cureus. 2019;11(9):e5690. doi:10.7759/cureus.5690.
   PubMed Web of Science ®Google Scholar
• Jeimy S, Tsoulis MW, Hachey J, Kim H. Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective. Allergy Asthma Clin Immunol. 2018;14:68. doi:10.1186/s13223-018-0301-6.
   PubMed Web of Science ®Google Scholar
• Reihman AE, Liu C, Cruse MH, Freid L, Perez N, Smith VL, Ferguson L, Wechsler M, Holguin F, Manka L, Sharma S. Clinical predictors of treatment failure to anti-IL5 therapy in severe eosinophilic asthma. B101 New biological treatments for asthma. American Thoracic Society International Conference Abstracts: American Thoracic Society; 2020. p. A4263–A4263. doi:10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A4263.
   Google Scholar
• Ortega G, Tongchinsub P, Carr T. Combination biologic therapy for severe persistent asthma. Ann Allergy Asthma Immunol. 2019;123(3):309–311. doi:10.1016/j.anai.2019.06.013.
   PubMed Web of Science ®Google Scholar
• van den Bosch WB, James AL, Tiddens HAWM. Structure and function of small airways in asthma patients revisited. Eur Respir Rev. 2021;30(159):200186. doi:10.1183/16000617.0186-2020.
   PubMed Web of Science ®Google Scholar
• Postma DS, Brightling C, Baldi S, Van den Berge M, Fabbri LM, Gagnatelli A, Papi A, Van der Molen T, Rabe KF, Siddiqui S, ATLANTIS study group, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med. 2019;7(5):402–416. doi:10.1016/S2213-2600(19)30049-9.
   PubMed Web of Science ®Google Scholar
• Usmani OS, Singh D, Spinola M, Bizzi A, Barnes PJ. The prevalence of small airways disease in adult asthma: a systematic literature review. Respir Med. 2016;116:19–27. doi:10.1016/j.rmed.2016.05.006.
   PubMed Web of Science ®Google Scholar
• Manoharan A, Anderson WJ, Lipworth J, Lipworth BJ. Assessment of spirometry and impulse oscillometry in relation to asthma control. Lung. 2015;193(1):47–51. doi:10.1007/s00408-014-9674-6.
   PubMed Web of Science ®Google Scholar
• Rao DR, Gaffin JM, Baxi SN, Sheehan WJ, Hoffman EB, Phipatanakul W. The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity. J Asthma. 2012;49(6):586–592. doi:10.3109/02770903.2012.690481.
   PubMed Web of Science ®Google Scholar
• Walenga RL, Longest PW. Current inhalers deliver very small doses to the lower tracheobronchial airways: assessment of healthy and constricted lungs. J Pharm Sci. 2016;105(1):147–159. doi:10.1016/j.xphs.2015.11.027.
   PubMed Web of Science ®Google Scholar
• de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW. Can ‘extrafine’ dry powder aerosols improve lung deposition? Eur J Pharm Biopharm. 2015;96:143–151. doi:10.1016/j.ejpb.2015.07.016.
   PubMed Web of Science ®Google Scholar
• Tiddens HAWM, Bos AC, Mouton JW, Devadason S, Janssens HM. Inhaled antibiotics: dry or wet? Eur Respir J. 2014;44(5):1308–1318. doi:10.1183/09031936.00090314.
   PubMed Web of Science ®Google Scholar
• Munro S, Vos W, Mignot B. P166 Use of in silico deposition modelling to evaluate the lung deposition patterns of budesonide delivered from different inhaler devices in patients with severe asthma. Thorax. 2018;73(Suppl 4):A192–A192. doi:10.1136/thorax-2018-212555.324.
   Web of Science ®Google Scholar
• Vogelmeier C, Kardos P, Hofmann T, Canisius S, Scheuch G, Muellinger B, Nocker K, Menz G, Rabe KF. Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. Eur Respir J. 2015;45(5):1273–1282. doi:10.1183/09031936.00152014.
   PubMed Web of Science ®Google Scholar
• Bakker EM, Volpi S, Salonini E, van der Wiel-Kooij EC, Sintnicolaas CJJCM, Hop WCJ, Assael BM, Merkus PJFM, Tiddens HAWM. Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation. Eur Respir J. 2011;38(6):1328–1335. doi:10.1183/09031936.00006211.
   PubMed Web of Science ®Google Scholar
• Mainz J, Canisius S, Scheuch G, et al. An open-label randomized pilot trial to evaluate tolerability, safety and applicability of budesonide inhalation suspension (BIS) delivered via akita jet in children aged 3-11 years with mild to moderate asthma. J Aerosol Med Pulmonary Drug Deliv. 2013;26A:A45.
   Web of Science ®Google Scholar
• Asthma GIf. Global Strategy for Asthma Management and Prevention 2020. 2020.
   Google Scholar
• Scott AM, Kolstoe S, Ploem MCC, Hammatt Z, Glasziou P. Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands. Health Res Policy Syst. 2020;18(1):11. doi:10.1186/s12961-019-0520-4.
   PubMed Web of Science ®Google Scholar
• Cooper BG, Stocks J, Hall GL, Culver B, Steenbruggen I, Carter KW, Thompson BR, Graham BL, Miller MR, Ruppel G, et al. The Global Lung Function Initiative (GLI) Network: bringing the world’s respiratory reference values together. Breathe (Sheff). 2017;13(3):e56–e64. doi:10.1183/20734735.012717.
   PubMedGoogle Scholar
• Brand P, Schulte M, Wencker M, Herpich CH, Klein G, Hanna K, Meyer T. Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J. 2009;34(2):354–360. doi:10.1183/09031936.00118408.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE) Guideline. Inhaled corticosteroid doses for NICE’s asthma guideline Last updated July 2018.
   Google Scholar
• Detry MA, Ma Y. Analyzing repeated measurements using mixed models. JAMA. 2016;315(4):407–408. doi:10.1001/jama.2015.19394.
   PubMed Web of Science ®Google Scholar
• Bakker EM, van der Wiel-Kooij EC, Müllinger B, Kroneberg P, Hop WCJ, Tiddens HAWM. Small-airways deposition of dornase alfa in children with asthma and persistent airway obstruction. J Allergy Clin Immunol. 2013;132(2):482–485 e10. doi:10.1016/j.jaci.2013.02.006.
   PubMed Web of Science ®Google Scholar
• Fischer A, Stegemann J, Scheuch G, Siekmeier R. Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials. Eur J Med Res. 2009;14 Suppl 4(Suppl 4):71–77. doi:10.1186/2047-783x-14-s4-71.
   PubMed Web of Science ®Google Scholar
• Konstantinos Katsoulis K, Kostikas K, Kontakiotis T. Techniques for assessing small airways function: Possible applications in asthma and COPD. Respir Med. 2016;119:e2–e9. doi:10.1016/j.rmed.2013.05.003.
   PubMedGoogle Scholar
• Maijers I, Kearns N, Harper J, Weatherall M, Beasley R. Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma. Eur Respir J. 2020;55(1):1901147. doi:10.1183/13993003.01147-2019.
   PubMed Web of Science ®Google Scholar
• Kaplan A, Price D. Treatment adherence in adolescents with asthma. J Asthma Allergy. 2020;13:39–49. doi:10.2147/jaa.S233268.
   PubMed Web of Science ®Google Scholar
• Weinstein JN. How do we move beyond regression to the mean? Improving health and health care. Spine (Phila Pa 1976). 2018;43(2):73–75. doi:10.1097/BRS.0000000000002504.
   PubMed Web of Science ®Google Scholar
• Stoloff SW, Kelly HW. Updates on the use of inhaled corticosteroids in asthma. Curr Opin Allergy Clin Immunol. 2011;11(4):337–344. doi:10.1097/ACI.0b013e328348a813.
   PubMed Web of Science ®Google Scholar